Piperidine compounds having the general general Formula I
wherein R1 is
a group having the general Formula II :
wherein X is CHR10, O, S, SO, SO2 or NR10, R10 being hydrogen, alkyl or alkenyl, an amino group, sulfonyl, optionally substituted phenyl or a hetero aromatic group; Y is CH, CH2, NH, C=O or C=S; Ra ― Rd are substituents; U is CH2, O or S; Q1 is a bond , alkylene or alkenylen and Q2 alkylene having at least two C-atoms or alkenylene
R2 and R3 are hydrogen, or alkyl or they may together form an ethylene or propylene bridge; R4 to R7 are substituents; and
Z1 is substituent, Z2 is hydrogen and Z3 is (CH2)n wherein n is 0;
show potent sigma receptor activity. Furthermore they show effect in animal models indicative of anxiolytic properties. Accordingly they are useful as medicines for the treatment of anxiety, psychosis, epilepsy, convulsion, movement disorders, motor disturbances, amnesia, cerebrovascular diseases, senile dementia of the Alzheimer type or Parkinson's disease.
具有一般通式 I 的
哌啶化合物
其中 R1 是
具有通式 II 的基团:
其中 X 是 CHR10、O、S、SO、SO2 或 NR10,R10 是氢、烷基或烯基、
氨基、磺酰基、任选取代的苯基或杂芳基;Y 是 CH、
CH2、NH、C=O 或 C=S;Ra - Rd 是取代基;U 是 、O 或 S;Q1 是键、亚烷基或烯基,Q2 是至少有两个 C 原子的亚烷基或烯基。
R2 和 R3 是氢、或烷基、或可共同形成
乙烯桥或
丙烯桥;R4 至 R7 是取代基;以及
Z1 为取代基,Z2 为氢,Z3 为 ( )n,其中 n 为 0;
显示出强大的 sigma 受体活性。此外,它们在动物模型中显示出抗焦虑特性。因此,它们可用作治疗焦虑症、精神病、癫痫、抽搐、运动障碍、运动失调、健忘症、脑血管疾病、阿尔茨海默型老年痴呆症或帕
金森病的药物。